Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lowest dose interleukin-2 immunotherapy.

× No keyword cloud information.

24 in total

1. Cellular but not humoral immune responses generated by vaccination with dendritic cells protect mice against leukaemia.

Authors: B M Colombo; R Lacave; C Pioche-Durieu; C Masurier; F M Lemoine; M Guigon; D Klatzmann
Journal: Immunology Date: 2000-01 Impact factor: 7.397

2. The soluble interleukin-2 receptor, peripheral blood, and reticulocyte fractions in acute pancreatitis.

Authors: T Salomone; P Boni; C Serra; A M Morselli-Labate; A L Di Gioia; M Romboli; A Guariento
Journal: Int J Pancreatol Date: 1996-12

Review 3. A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection.

Authors: S C Piscitelli; N Bhat; A Pau
Journal: Drug Saf Date: 2000-01 Impact factor: 5.606

Review 4. X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

Authors: N L Farner; S D Voss; P M Sondel
Journal: Clin Diagn Lab Immunol Date: 1995-09

Review 5. Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors: Andrew M Shen; Tamara Minko
Journal: J Control Release Date: 2020-07-16 Impact factor: 9.776

6. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

Authors: E L Jacobson; F Pilaro; K A Smith
Journal: Proc Natl Acad Sci U S A Date: 1996-09-17 Impact factor: 11.205

Lowest dose interleukin-2 immunotherapy.

1. Cellular but not humoral immune responses generated by vaccination with dendritic cells protect mice against leukaemia.

2. The soluble interleukin-2 receptor, peripheral blood, and reticulocyte fractions in acute pancreatitis.

Review 3. A risk-benefit assessment of interleukin-2 as an adjunct to antiviral therapy in HIV infection.

Review 4. X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

Review 5. Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

6. Rational interleukin 2 therapy for HIV positive individuals: daily low doses enhance immune function without toxicity.

Review 7. Interleukin-2. A review of its pharmacological properties and therapeutic use in patients with cancer.

8. Attenuated Salmonella typhimurium with IL-2 gene reduces pulmonary metastases in murine osteosarcoma.

9. Clinical and immunological effect of intravesical interleukin-2 on superficial bladder cancer.

10. Role of common gamma chain utilizing cytokines for immune reconstitution in HIV infection.